Please provide your email address to receive an email when new articles are posted on . Janssen Research & Development announced the launch of three new clinical trials to evaluate rivaroxaban for the ...

XARELTO (rivaroxaban) 20mg tablets Janssen announced that the FDA has approved Xarelto (rivaroxaban), an oral anticoagulant, for the treatment of deep vein thrombosis (DVT) and/or pulmonary embolism ...

Bayer's Xarelto® (Rivaroxaban) Approved for the Treatment of Pulmonary Embolism (PE) and the Prevention of Recurrent Deep Vein Thrombosis (DVT) and PE in the EU Blood clots obstructing blood flow in ...

Janssen Research & Development announced that the FDA has assigned a priority review designation to the supplemental New Drug Applications (sNDAs) for Xarelto (rivaroxaban) seeking new indications to ...

The FDA today expanded the indication for rivaroxaban (Xarelto, Johnson & Johnson) to include the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) and to reduce the risk of ...

The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of ...

Xarelto approved for pulmonary embolism, DVT The FDA has expanded indications for rivarobaxan to include pulmonary embolism and deep vein thrombosis. The FDA has voted in favor of expanding ...

The “triple aim” promised by healthcare reform—better-quality care, greater patient satisfaction, at a lower cost—will play out procedure by procedure as physicians find ways to deliver better ...

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...

The European Commission has given the green light to a new indication for rivaroxaban (Xarelto, Bayer). Rivaroxaban, which earned approval as a warfarin alternative for the prevention of stroke and ...

Pulmonary embolism (acute treatment, VTE prevention - rivaroxaban: appendix A draft scope for consultation (post referral) October 2012 Pulmonary embolism (acute treatment, VTE prevention - ...